{"doi":"10.1007/978-3-658-17276-3_7","title":"Conclusions and Recommendations","abstract":null,"journal":"Pharmacovigilance in the European Union","year":2017,"id":26174,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":152022,"name":"Julia Schmälter","orcid":null,"position":1,"is_corresponding":false},{"id":152023,"name":"Christoph Klika","orcid":null,"position":2,"is_corresponding":false},{"id":152021,"name":"Michael Kaeding","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"18998881","pmcid":null,"openalex_id":"https://openalex.org/W4239234832","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.44607843,"influential_citations":0,"citation_trend":[],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://link.springer.com/content/pdf/10.1007/978-3-658-17276-3_7.pdf","host_type":""},{"url":"https://link.springer.com/content/pdf/10.1007/978-3-658-17276-3_7.pdf","host_type":""},{"url":"http://link.springer.com/content/pdf/10.1007/978-3-658-17276-3_7","host_type":"publisher"},{"url":"https://doi.org/10.1007/978-3-658-17276-3_7","host_type":""}],"fields_of_study":["Pharmacovigilance and Adverse Drug Reactions","Meta-analysis and systematic reviews","Pharmaceutical industry and healthcare"],"mesh_terms":[],"keywords":["Pharmacovigilance","Marketing authorization","Authorization","Medicine","Adverse effect","Drug reaction","European union","Business","Adverse drug reaction","Drug","Pharmacology","Computer security","Bioinformatics","Computer science"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T12:17:39.548202Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}